| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 580.446.914 $ | -238.909.706 $ | -2,0 % | 76 | 1.036.774.422 $ | +619.223.434 $ | +297,1 % | 75 | 583.203.176 $ | +209.177.596 $ | +248,1 % | 75 | 499.059.412 $ | +252.563.146 $ | +151,0 % | 79 | ||||
| Scholar Rock Holding Corp | SRRK | → 0 | Neutral | 13.153.030 $ | -89.832.936 $ | -87,2 % | 1 | 102.985.966 $ | +63.433.579 $ | +160,4 % | 1 | 39.552.387 $ | +12.484.630 $ | +46,1 % | 1 | 27.067.757 $ | +8.361.924 $ | +44,7 % | 1 |
| Abivax S.A. | ABVX | → 0 | Schwach | 37.800.132 $ | -32.081.124 $ | -45,9 % | 1 | 69.881.256 $ | +17.047.360 $ | +32,3 % | 1 | 52.833.896 $ | +38.717.318 $ | +274,3 % | 1 | 14.116.578 $ | +13.445.306 $ | +2.003,0 % | 1 |
| Roivant Sciences Ltd. | ROIV | → 0 | Schwach | 12.370.159 $ | -9.003.161 $ | -42,1 % | 1 | 21.373.320 $ | +395.973 $ | +1,9 % | 1 | 20.977.347 $ | -42.526.092 $ | -67,0 % | 1 | 63.503.439 $ | +56.103.742 $ | +758,2 % | 1 |
| Syndax Pharmaceuticals Inc | SNDX | → 0 | Sehr schwach | 56.979.512 $ | +28.839.159 $ | +102,5 % | 1 | 28.140.353 $ | +7.066.289 $ | +33,5 % | 1 | 21.074.064 $ | -1.145.653 $ | -5,2 % | 1 | ||||
| Revolution Medicines, Inc. | RVMD | → 0 | Neutral | 30.081.625 $ | -25.745.799 $ | -46,1 % | 1 | 55.827.424 $ | +50.886.575 $ | +1.029,9 % | 1 | 4.940.849 $ | -3.716.397 $ | -42,9 % | 1 | 8.657.246 $ | +8.657.246 $ | 1 | |
| Tango Therapeutics, Inc. | TNGX | → 0 | Schwach | 38.406.574 $ | +30.000.124 $ | +356,9 % | 1 | 8.406.450 $ | +6.345.275 $ | +307,8 % | 1 | 2.061.175 $ | +992.119 $ | +92,8 % | 1 | ||||
| Immunovant, Inc. | IMVT | → 0 | Neutral | 10.654.585 $ | -26.941.237 $ | -71,7 % | 1 | 37.595.822 $ | +21.200.964 $ | +129,3 % | 1 | 16.394.858 $ | -9.279.172 $ | -36,1 % | 1 | 25.674.030 $ | +4.550.270 $ | +21,5 % | 1 |
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Sehr schwach | 12.468.584 $ | -23.788.746 $ | -65,6 % | 1 | 36.257.330 $ | +30.048.042 $ | +483,9 % | 1 | 6.209.288 $ | +4.852.965 $ | +357,8 % | 1 | ||||
| uniQure N.V. | QURE | → 0 | Neutral | 4.058.577 $ | +1.505.819 $ | +59,0 % | 1 | 2.552.758 $ | +1.512.162 $ | +145,3 % | 1 | 1.040.596 $ | -29.437.591 $ | -96,6 % | 1 | 30.478.187 $ | +22.495.934 $ | +281,8 % | 1 |
| MBX Biosciences, Inc. | MBX | → 0 | Neutral | 29.818.300 $ | +27.340.738 $ | +1.103,5 % | 1 | 2.477.562 $ | +1.165.062 $ | +88,8 % | 1 | 1.312.500 $ | -296.550 $ | -18,4 % | 1 | ||||
| Mineralys Therapeutics, Inc. | MLYS | → 0 | Neutral | 16.260.468 $ | -12.637.952 $ | -43,7 % | 1 | 28.898.420 $ | +18.372.542 $ | +174,5 % | 1 | 10.525.878 $ | +4.530.271 $ | +75,6 % | 1 | 5.995.607 $ | -2.555.436 $ | -29,9 % | 1 |
| Centessa Pharmaceuticals plc | CNTA | → 0 | 28.890.641 $ | +12.091.930 $ | +72,0 % | 1 | 16.798.711 $ | +167.781 $ | +1,0 % | 1 | |||||||||
| Erasca, Inc. | ERAS | → 0 | Schwach | 28.777.526 $ | +21.015.624 $ | +270,8 % | 1 | 7.761.902 $ | +7.761.902 $ | 1 | |||||||||
| Enliven Therapeutics, Inc. | ELVN | → 0 | Stark | 17.605.886 $ | -10.887.654 $ | -38,2 % | 1 | 28.493.540 $ | +28.493.540 $ | 1 | |||||||||
| CG Oncology, Inc. | CGON | → 0 | Schwach | 11.321.746 $ | -16.511.248 $ | -59,3 % | 1 | 27.832.994 $ | +25.294.589 $ | +996,5 % | 1 | 2.538.405 $ | +2.538.405 $ | 1 | |||||
| Biohaven Ltd. | BHVN | → 0 | Neutral | 16.360.296 $ | -10.618.492 $ | -39,4 % | 1 | 26.978.788 $ | +10.520.950 $ | +63,9 % | 1 | 16.457.838 $ | +13.992.059 $ | +567,4 % | 1 | ||||
| Denali Therapeutics Inc. | DNLI | → 0 | Stark | 16.379.942 $ | +9.461.294 $ | +136,8 % | 1 | 6.918.648 $ | -18.268.601 $ | -72,5 % | 1 | 25.187.249 $ | +15.283.518 $ | +154,3 % | 1 | ||||
| Structure Therapeutics Inc. | GPCR | → 0 | Neutral | 2.049.013 $ | -17.256.725 $ | -89,4 % | 1 | 19.305.738 $ | -5.111.389 $ | -20,9 % | 1 | 24.417.127 $ | +20.795.747 $ | +574,2 % | 1 | 3.621.380 $ | +3.621.380 $ | 1 | |
| Arcellx, Inc. | ACLX | → 0 | 21.702.472 $ | +20.768.502 $ | +2.223,7 % | 1 | 933.970 $ | -12.331.644 $ | -93,0 % | 1 | |||||||||
| EyePoint, Inc. | EYPT | → 0 | Schwach | 4.840.135 $ | -16.061.361 $ | -76,8 % | 1 | 20.901.496 $ | +14.436.675 $ | +223,3 % | 1 | 6.464.821 $ | +3.366.541 $ | +108,7 % | 1 | ||||
| Tyra Biosciences, Inc. | TYRA | → 0 | Neutral | 20.210.163 $ | +4.832.805 $ | +31,4 % | 1 | 15.377.358 $ | +15.377.358 $ | 1 | |||||||||
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Schwach | 19.578.955 $ | +5.228.299 $ | +36,4 % | 1 | 14.350.656 $ | +11.083.362 $ | +339,2 % | 1 | 3.267.294 $ | +1.638.912 $ | +100,6 % | 1 | 1.628.382 $ | +1.628.382 $ | 1 | |
| Arcutis Biotherapeutics, Inc. | ARQT | → 0 | Neutral | 2.594.338 $ | -16.903.542 $ | -86,7 % | 1 | 19.497.880 $ | +12.971.430 $ | +198,8 % | 1 | 6.526.450 $ | -1.237.733 $ | -15,9 % | 1 | 7.764.183 $ | +4.880.662 $ | +169,3 % | 1 |
| Surrozen, Inc./DE | SRZN | → 0 | Neutral | 13.786.568 $ | -5.383.354 $ | -28,1 % | 1 | 19.169.922 $ | +6.497.814 $ | +51,3 % | 1 | 12.672.108 $ | +3.479.137 $ | +37,8 % | 1 | 9.192.971 $ | +3.055.312 $ | +49,8 % | 1 |
| Amylyx Pharmaceuticals, Inc. | AMLX | → 0 | Stark | 6.902.100 $ | -11.715.144 $ | -62,9 % | 1 | 18.617.244 $ | +11.790.353 $ | +172,7 % | 1 | 6.826.891 $ | +3.064.923 $ | +81,5 % | 1 | 3.761.968 $ | +3.761.968 $ | 1 | |
| Dyne Therapeutics, Inc. | DYN | → 0 | Schwach | 18.350.280 $ | +2.013.768 $ | +12,3 % | 1 | 16.336.512 $ | +10.332.670 $ | +172,1 % | 1 | 6.003.842 $ | +6.003.842 $ | 1 | |||||
| Edgewise Therapeutics, Inc. | EWTX | → 0 | Neutral | 18.324.432 $ | +9.369.294 $ | +104,6 % | 1 | 8.955.138 $ | +8.955.138 $ | 1 | |||||||||
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 15.000 $ | -17.324.599 $ | -99,9 % | 1 | 17.339.599 $ | +16.666.575 $ | +2.476,4 % | 1 | 673.024 $ | +673.024 $ | 1 | ||||||
| CYTOKINETICS INC | CYTK | → 0 | Schwach | 6.440.620 $ | -10.640.220 $ | -62,3 % | 1 | 17.080.840 $ | +7.741.858 $ | +82,9 % | 1 | 9.338.982 $ | +9.338.982 $ | 1 | |||||
| Spyre Therapeutics, Inc. | SYRE | → 0 | Neutral | 9.492.890 $ | -7.415.204 $ | -43,9 % | 1 | 16.908.094 $ | +15.847.423 $ | +1.494,1 % | 1 | 1.060.671 $ | +1.060.671 $ | 1 | |||||
| Twist Bioscience Corp | TWST | → 0 | Neutral | 4.097.174 $ | -12.345.047 $ | -75,1 % | 1 | 16.442.221 $ | +16.442.221 $ | 1 | |||||||||
| Xenon Pharmaceuticals Inc. | XENE | → 0 | Neutral | 4.591.887 $ | -11.777.919 $ | -71,9 % | 1 | 16.369.806 $ | +745.330 $ | +4,8 % | 1 | 15.624.476 $ | +7.903.832 $ | +102,4 % | 1 | 7.720.644 $ | +7.720.644 $ | 1 | |
| Celldex Therapeutics, Inc. | CLDX | → 0 | Neutral | 6.638.711 $ | -9.491.987 $ | -58,8 % | 1 | 16.130.698 $ | +16.130.698 $ | 1 | |||||||||
| Wave Life Sciences, Inc. | WVE | → 0 | 15.446.313 $ | +9.594.116 $ | +163,9 % | 1 | |||||||||||||
| Protagonist Therapeutics, Inc | PTGX | → 0 | Stark | 1.998.422 $ | -13.300.810 $ | -86,9 % | 1 | 15.299.232 $ | +10.108.616 $ | +194,7 % | 1 | 5.190.616 $ | +2.005.032 $ | +62,9 % | 1 | 3.185.584 $ | +2.258.823 $ | +243,7 % | 1 |
| Cidara Therapeutics, Inc. | → 0 | 14.586.642 $ | +1.592.080 $ | +12,3 % | 1 | ||||||||||||||
| Celcuity Inc. | CELC | → 0 | Neutral | 10.273.998 $ | -3.436.956 $ | -25,1 % | 1 | 13.710.954 $ | +1.908.421 $ | +16,2 % | 1 | 11.802.533 $ | +5.049.059 $ | +74,8 % | 1 | 6.753.474 $ | +6.753.474 $ | 1 | |
| Kiniksa Pharmaceuticals International, plc | KNSA | → 0 | Stark | 13.380.514 $ | +13.380.514 $ | 1 | |||||||||||||
| Alkermes plc. | ALKS | → 0 | Neutral | 12.994.746 $ | +7.302.352 $ | +128,3 % | 1 | 5.692.394 $ | -1.556.716 $ | -21,5 % | 1 | 7.249.110 $ | -2.793.388 $ | -27,8 % | 1 | ||||
| First Tracks Biotherapeutics, Inc. | TRAX | → 0 | Neutral | 12.529.187 $ | +12.529.187 $ | 1 | |||||||||||||
| Definium Therapeutics, Inc. | DFTX | → 0 | Neutral | 6.450.313 $ | -5.852.945 $ | -47,6 % | 1 | 12.303.258 $ | +11.396.902 $ | +1.257,4 % | 1 | 906.356 $ | +316.727 $ | +53,7 % | 1 | ||||
| BioAge Labs, Inc. | BIOA | → 0 | Neutral | 11.376.831 $ | -469.285 $ | -4,0 % | 1 | 11.846.116 $ | +11.846.116 $ | 1 | |||||||||
| NewAmsterdam Pharma Co N.V. | NAMS | → 0 | Schwach | 2.629.491 $ | -8.936.235 $ | -77,3 % | 1 | 11.565.726 $ | +9.001.168 $ | +351,0 % | 1 | 2.564.558 $ | -1.717.738 $ | -40,1 % | 1 | 4.282.296 $ | +1.517.768 $ | +54,9 % | 1 |
| Oruka Therapeutics, Inc. | ORKA | → 0 | Neutral | 11.083.593 $ | +11.083.593 $ | 1 | |||||||||||||
| ACADIA PHARMACEUTICALS INC | ACAD | → 0 | Stark | 3.622.125 $ | -7.176.913 $ | -66,5 % | 1 | 10.799.038 $ | +10.799.038 $ | 1 | |||||||||
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | → 0 | Sehr schwach | 10.328.382 $ | +6.564.159 $ | +174,4 % | 1 | 3.764.223 $ | -12.183.089 $ | -76,4 % | 1 | ||||||||
| ASSEMBLY BIOSCIENCES, INC. | ASMB | → 0 | Stark | 4.681.987 $ | -5.609.655 $ | -54,5 % | 1 | 10.291.642 $ | +4.961.323 $ | +93,1 % | 1 | 5.330.319 $ | +3.637.391 $ | +214,9 % | 1 | 1.692.928 $ | +1.692.928 $ | 1 | |
| IDEAYA Biosciences, Inc. | IDYA | → 0 | Neutral | 5.588.552 $ | -4.528.806 $ | -44,8 % | 1 | 10.117.358 $ | +6.630.455 $ | +190,2 % | 1 | ||||||||
| ALUMIS INC. | ALMS | → 0 | Schwach | 3.819.611 $ | -6.295.067 $ | -62,2 % | 1 | 10.114.678 $ | +10.114.678 $ | 1 | |||||||||
| RELMADA THERAPEUTICS, INC. | RLMD | → 0 | Neutral | 10.103.844 $ | +1.787.910 $ | +21,5 % | 1 | 8.315.934 $ | +8.315.934 $ | 1 | |||||||||
| Adaptive Biotechnologies Corp | ADPT | → 0 | Neutral | 9.854.838 $ | +9.854.838 $ | 1 | |||||||||||||
| PALISADE BIO, INC. | PALI | → 0 | Neutral | 9.852.081 $ | +9.852.081 $ | 1 | |||||||||||||
| Nurix Therapeutics, Inc. | NRIX | → 0 | Neutral | 9.772.006 $ | +9.772.006 $ | 1 | |||||||||||||
| Climb Bio, Inc. | CLYM | → 0 | Neutral | 9.685.395 $ | +9.685.395 $ | 1 | |||||||||||||
| RHYTHM PHARMACEUTICALS, INC. | RYTM | → 0 | Neutral | 6.306.262 $ | -2.928.668 $ | -31,7 % | 1 | 9.234.930 $ | -1.934.029 $ | -17,3 % | 1 | ||||||||
| ARGENX SE | ARGX | → 0 | Stark | 9.193.685 $ | +9.193.685 $ | 1 | |||||||||||||
| Zura Bio Ltd | ZURA | → 0 | Neutral | 8.072.469 $ | -894.419 $ | -10,0 % | 1 | 8.966.888 $ | +8.966.888 $ | 1 | |||||||||
| Evommune, Inc. | EVMN | → 0 | Schwach | 8.770.714 $ | +7.603.198 $ | +651,2 % | 1 | 1.167.516 $ | +1.167.516 $ | 1 | |||||||||
| Rezolute, Inc. | RZLT | → 0 | Neutral | 8.625.722 $ | +5.750.565 $ | +200,0 % | 1 | ||||||||||||
| Faeth Therapeutics, Inc. | SNSE | → 0 | 8.376.314 $ | +8.376.314 $ | 1 | ||||||||||||||
| GH Research PLC | GHRS | → 0 | Neutral | 7.797.433 $ | +6.568.364 $ | +534,4 % | 1 | ||||||||||||
| Vistagen Therapeutics, Inc. | VTGN | → 0 | Schwach | 17.276 $ | -99.098 $ | -85,2 % | 1 | 116.374 $ | -25.712 $ | -18,1 % | 1 | 142.086 $ | -7.607.177 $ | -98,2 % | 1 | 7.749.263 $ | +3.631.883 $ | +88,2 % | 1 |
| BRIGHT MINDS BIOSCIENCES INC. | DRUG | → 0 | Neutral | 7.596.414 $ | +7.596.414 $ | 1 | |||||||||||||
| NEKTAR THERAPEUTICS | NKTR | → 0 | Neutral | 7.537.425 $ | +4.510.288 $ | +149,0 % | 1 | 3.027.137 $ | +3.027.137 $ | 1 | |||||||||
| JOHNSON & JOHNSON | JNJ | → 0 | Neutral | 7.536.086 $ | +292.836 $ | +4,0 % | 1 | 7.243.250 $ | +7.243.250 $ | 1 | |||||||||
| InflaRx N.V. | IFRX | → 0 | Neutral | 7.231.291 $ | +7.231.291 $ | 1 | |||||||||||||
| X4 Pharmaceuticals, Inc | XFOR | → 0 | Neutral | 7.027.128 $ | +3.433.268 $ | +95,5 % | 1 | 3.593.860 $ | +1.694.354 $ | +89,2 % | 1 | 1.899.506 $ | +1.899.506 $ | 1 | |||||
| Vaxcyte, Inc. | PCVX | → 0 | Neutral | 6.864.070 $ | +6.864.070 $ | 1 | |||||||||||||
| BridgeBio Pharma, Inc. | BBIO | → 0 | Neutral | 6.618.974 $ | +4.260.051 $ | +180,6 % | 1 | ||||||||||||
| ClearPoint Neuro, Inc. | CLPT | → 0 | Neutral | 6.591.817 $ | +6.228.992 $ | +1.716,8 % | 1 | 362.825 $ | +362.825 $ | 1 | |||||||||
| Ovid Therapeutics Inc. | OVID | → 0 | Schwach | 6.502.491 $ | +6.502.491 $ | 1 | |||||||||||||
| Whitehawk Therapeutics, Inc. | WHWK | → 0 | Neutral | 4.676.349 $ | -1.805.297 $ | -27,9 % | 1 | 6.481.646 $ | +2.951.333 $ | +83,6 % | 1 | 3.530.313 $ | +2.724.557 $ | +338,1 % | 1 | 805.756 $ | +805.756 $ | 1 | |
| Equillium, Inc. | EQ | → 0 | Neutral | 6.453.142 $ | +3.723.365 $ | +136,4 % | 1 | 2.729.777 $ | +2.729.777 $ | 1 | |||||||||
| Immatics N.V. | IMTX | → 0 | Neutral | 6.408.234 $ | +6.408.234 $ | 1 | |||||||||||||
| OCULAR THERAPEUTIX, INC | OCUL | → 0 | Schwach | 6.345.493 $ | +2.143.289 $ | +51,0 % | 1 | 4.202.204 $ | +4.202.204 $ | 1 | |||||||||
| INSMED Inc | INSM | → 0 | Schwach | 6.251.468 $ | +54.258 $ | +0,9 % | 1 | ||||||||||||
| Helix Acquisition Corp. III | HLXC | → 0 | 1.826.579 $ | -4.371.589 $ | -70,5 % | 1 | 6.198.168 $ | +6.198.168 $ | 1 | ||||||||||
| Apogee Therapeutics, Inc. | APGE | → 0 | Neutral | 6.081.726 $ | +2.413.368 $ | +65,8 % | 1 | ||||||||||||
| INCYTE CORP | INCY | → 0 | Stark | 6.067.935 $ | +2.357.158 $ | +63,5 % | 1 | 3.710.777 $ | +3.710.777 $ | 1 | |||||||||
| TENAX THERAPEUTICS, INC. | TENX | → 0 | Neutral | 1.400.772 $ | -4.633.854 $ | -76,8 % | 1 | 6.034.626 $ | +6.034.626 $ | 1 | |||||||||
| Akero Therapeutics, Inc. | → 0 | 5.774.235 $ | -457.092 $ | -7,3 % | 1 | ||||||||||||||
| Damora Therapeutics, Inc. | GLTO | → 0 | 5.623.206 $ | +5.623.206 $ | 1 | ||||||||||||||
| Inventiva S.A. | IVA | → 0 | Neutral | 5.391.490 $ | +3.218.815 $ | +148,1 % | 1 | 2.172.675 $ | +1.994.204 $ | +1.117,4 % | 1 | 178.471 $ | +178.471 $ | 1 | |||||
| Century Therapeutics, Inc. | IPSC | → 0 | Neutral | 5.258.146 $ | +5.258.146 $ | 1 | |||||||||||||
| Maze Therapeutics, Inc. | MAZE | → 0 | Neutral | 5.215.084 $ | +5.215.084 $ | 1 | |||||||||||||
| Jazz Pharmaceuticals plc | JAZZ | → 0 | Neutral | 5.149.690 $ | +5.149.690 $ | 1 | |||||||||||||
| ELI LILLY & Co | LLY | → 0 | Stark | 5.114.402 $ | +5.114.402 $ | 1 | |||||||||||||
| Aura Biosciences, Inc. | AURA | → 0 | Neutral | 5.071.388 $ | +5.071.388 $ | 1 | |||||||||||||
| Trevi Therapeutics, Inc. | TRVI | → 0 | Schwach | 5.002.454 $ | +1.793.457 $ | +55,9 % | 1 | 3.208.997 $ | +3.208.997 $ | 1 | |||||||||
| Avidity Biosciences, Inc. | RNA | → 0 | 4.969.289 $ | +4.969.289 $ | 1 | ||||||||||||||
| Pharvaris N.V. | PHVS | → 0 | Neutral | 2.797.764 $ | -2.097.226 $ | -42,8 % | 1 | 4.894.990 $ | +3.274.695 $ | +202,1 % | 1 | 1.620.295 $ | +1.620.295 $ | 1 | |||||
| Invivyd, Inc. | IVVD | → 0 | Sehr schwach | 4.873.820 $ | +2.428.960 $ | +99,3 % | 1 | 2.444.860 $ | +2.138.391 $ | +697,8 % | 1 | 306.469 $ | +306.469 $ | 1 | |||||
| Viridian Therapeutics, Inc.\DE | VRDN | → 0 | Neutral | 4.802.438 $ | +4.802.438 $ | 1 | |||||||||||||
| Arbutus Biopharma Corp | ABUS | → 0 | Neutral | 4.746.272 $ | +3.804.310 $ | +403,9 % | 1 | 941.962 $ | +941.962 $ | 1 | |||||||||
| MoonLake Immunotherapeutics | MLTX | → 0 | Schwach | 4.591.925 $ | +4.591.925 $ | 1 | |||||||||||||
| CytomX Therapeutics, Inc. | CTMX | → 0 | Neutral | 4.414.685 $ | +4.414.685 $ | 1 | |||||||||||||
| Jade Biosciences, Inc. | JBIO | → 0 | Schwach | 4.328.356 $ | +4.328.356 $ | 1 | |||||||||||||
| Personalis, Inc. | PSNL | → 0 | Schwach | 4.131.042 $ | +4.131.042 $ | 1 | |||||||||||||
| MapLight Therapeutics, Inc. | MPLT | → 0 | Neutral | 3.831.511 $ | -234.489 $ | -5,8 % | 1 | 4.066.000 $ | +2.309.500 $ | +131,5 % | 1 | 1.756.500 $ | +1.756.500 $ | 1 | |||||
| COMPASS Pathways plc | CMPS | → 0 | Neutral | 4.029.481 $ | +2.450.178 $ | +155,1 % | 1 | 1.579.303 $ | +1.579.303 $ | 1 | |||||||||
| Avalo Therapeutics, Inc. | AVTX | → 0 | Schwach | 4.023.396 $ | +1.561.772 $ | +63,4 % | 1 | 2.461.624 $ | +2.461.624 $ | 1 | |||||||||
| IONIS PHARMACEUTICALS INC | IONS | → 0 | Schwach | 3.962.500 $ | +3.825.000 $ | +2.781,8 % | 1 | 137.500 $ | +137.500 $ | 1 | |||||||||
| Avalyn Pharma Inc. | AVLN | → 0 | 3.884.560 $ | +3.884.560 $ | 1 | ||||||||||||||
| Immunocore Holdings plc | IMCR | → 0 | Neutral | 3.831.642 $ | +3.831.642 $ | 1 | |||||||||||||
| Axsome Therapeutics, Inc. | AXSM | → 0 | Schwach | 3.763.339 $ | +3.763.339 $ | 1 | |||||||||||||
| Monte Rosa Therapeutics, Inc. | GLUE | → 0 | Neutral | 3.715.765 $ | +2.750.238 $ | +284,8 % | 1 | 965.527 $ | +965.527 $ | 1 | |||||||||
| Solid Biosciences Inc. | SLDB | → 0 | Schwach | 3.584.212 $ | +770.408 $ | +27,4 % | 1 | 2.813.804 $ | +2.813.804 $ | 1 | |||||||||
| CRESCENT BIOPHARMA, INC. | CBIO | → 0 | Neutral | 3.282.876 $ | +3.282.876 $ | 1 | |||||||||||||
| ARROWHEAD PHARMACEUTICALS, INC. | ARWR | → 0 | Neutral | 3.195.029 $ | +3.195.029 $ | 1 | |||||||||||||
| Ascendis Pharma A/S | ASND | → 0 | 3.164.908 $ | +153.135 $ | +5,1 % | 1 | 3.011.773 $ | +3.011.773 $ | 1 | ||||||||||
| Forte Biosciences, Inc. | FBRX | → 0 | Sehr schwach | 3.005.436 $ | +3.005.436 $ | 1 | |||||||||||||
| Tectonic Therapeutic, Inc. | TECX | → 0 | Neutral | 2.965.394 $ | +2.170.594 $ | +273,1 % | 1 | ||||||||||||
| Kodiak Sciences Inc. | KOD | → 0 | Neutral | 2.955.973 $ | +2.955.973 $ | 1 | |||||||||||||
| Sionna Therapeutics, Inc. | SION | → 0 | Neutral | 2.614.150 $ | -315.628 $ | -10,8 % | 1 | 2.929.778 $ | +2.929.778 $ | 1 | |||||||||
| SAB Biotherapeutics, Inc. | SABS | → 0 | Neutral | 1.336.261 $ | -1.536.239 $ | -53,5 % | 1 | 2.872.500 $ | +2.324.373 $ | +424,1 % | 1 | 548.127 $ | +548.127 $ | 1 | |||||
| Monopar Therapeutics | MNPR | → 0 | Schwach | 2.789.274 $ | +2.789.274 $ | 1 | |||||||||||||
| HARROW, INC. | HROW | → 0 | Schwach | 2.776.083 $ | +2.776.083 $ | 1 | |||||||||||||
| Rapport Therapeutics, Inc. | RAPP | → 0 | Schwach | 2.774.472 $ | +2.774.472 $ | 1 | |||||||||||||
| Taysha Gene Therapies, Inc. | TSHA | → 0 | Neutral | 1.001.715 $ | -1.744.003 $ | -63,5 % | 1 | 2.745.718 $ | -35.386 $ | -1,3 % | 1 | ||||||||
| UNITED THERAPEUTICS Corp | UTHR | → 0 | Neutral | 2.625.931 $ | +2.625.931 $ | 1 | |||||||||||||
| REPLIGEN CORP | RGEN | → 0 | Neutral | 2.573.749 $ | +2.573.749 $ | 1 | |||||||||||||
| Lipocine Inc. | LPCN | → 0 | 2.563.512 $ | +2.563.512 $ | 1 | ||||||||||||||
| Quince Therapeutics, Inc. | QNCX | → 0 | Schwach | 2.476.534 $ | +2.476.534 $ | 1 | |||||||||||||
| LB PHARMACEUTICALS INC | LBRX | → 0 | Schwach | 1.031.582 $ | -1.434.418 $ | -58,2 % | 1 | 2.466.000 $ | +2.466.000 $ | 1 | |||||||||
| C4 Therapeutics, Inc. | CCCC | → 0 | Neutral | 2.445.436 $ | +61.414 $ | +2,6 % | 1 | 2.384.022 $ | +2.384.022 $ | 1 | |||||||||
| Edwards Lifesciences Corp | EW | → 0 | Neutral | 2.338.414 $ | +2.338.414 $ | 1 | |||||||||||||
| MeiraGTx Holdings plc | MGTX | → 0 | Sehr schwach | 2.287.128 $ | +1.613.437 $ | +239,5 % | 1 | 673.691 $ | +673.691 $ | 1 | |||||||||
| CAPRICOR THERAPEUTICS, INC. | CAPR | → 0 | Sehr schwach | 2.285.594 $ | +1.770.356 $ | +343,6 % | 1 | 515.238 $ | +515.238 $ | 1 | |||||||||
| INVESCO QQQ TRUST, SERIES 1 | QQQ | → 0 | 148.400 $ | -2.131.205 $ | -93,5 % | 1 | 2.279.605 $ | +2.279.605 $ | 1 | ||||||||||
| SPRUCE BIOSCIENCES, INC. | SPRB | → 0 | Schwach | 2.234.952 $ | +1.403.700 $ | +168,9 % | 1 | 831.252 $ | +831.252 $ | 1 | |||||||||
| BridgeBio Oncology Therapeutics, Inc. | BBOT | → 0 | Schwach | 1.083.193 $ | -1.077.797 $ | -49,9 % | 1 | 2.160.990 $ | -1.129.866 $ | -34,3 % | 1 | ||||||||
| AbbVie Inc. | ABBV | → 0 | Neutral | 2.130.669 $ | +2.130.669 $ | 1 | |||||||||||||
| Cue Biopharma, Inc. | CUE | → 0 | Schwach | 2.114.362 $ | +2.114.362 $ | 1 | |||||||||||||
| BIODESIX INC | BDSX | → 0 | Neutral | 1.578.500 $ | -451.616 $ | -22,2 % | 1 | 2.030.116 $ | +2.030.116 $ | 1 | |||||||||
| Oric Pharmaceuticals, Inc. | ORIC | → 0 | Sehr schwach | 1.997.532 $ | -40.436 $ | -2,0 % | 1 | ||||||||||||
| PepGen Inc. | PEPG | → 0 | Schwach | 1.798.053 $ | +1.798.053 $ | 1 | |||||||||||||
| ADC Therapeutics SA | ADCT | → 0 | Schwach | 1.774.072 $ | +640.928 $ | +56,6 % | 1 | 1.133.144 $ | +373.938 $ | +49,3 % | 1 | ||||||||
| Legend Biotech Corp | LEGN | → 0 | Neutral | 1.594.151 $ | -7.993.260 $ | -83,4 % | 1 | ||||||||||||
| Freenome, Inc. | PCSC | → 0 | 1.590.000 $ | -3.000 $ | -0,2 % | 1 | |||||||||||||
| Protara Therapeutics, Inc. | TARA | → 0 | Neutral | 1.581.947 $ | -1.883.394 $ | -54,3 % | 1 | ||||||||||||
| Pyxis Oncology, Inc. | PYXS | → 0 | Schwach | 1.530.774 $ | +1.530.774 $ | 1 | |||||||||||||
| BELITE BIO, INC | BLTE | → 0 | Neutral | 1.465.713 $ | +1.465.713 $ | 1 | |||||||||||||
| Xilio Therapeutics, Inc. | XLO | → 0 | 1.299.624 $ | +1.299.624 $ | 1 | ||||||||||||||
| CalciMedica, Inc. | CALC | → 0 | Sehr schwach | 1.195.661 $ | +1.195.661 $ | 1 | |||||||||||||
| SUTRO BIOPHARMA, INC. | STRO | → 0 | Neutral | 1.160.556 $ | +1.160.556 $ | 1 | |||||||||||||
| Cellectar Biosciences, Inc. | CLRB | → 0 | 986.728 $ | +986.728 $ | 1 | ||||||||||||||
| ENANTA PHARMACEUTICALS INC | ENTA | → 0 | Neutral | 900.072 $ | +900.072 $ | 1 | |||||||||||||
| Zenas BioPharma, Inc. | ZBIO | → 0 | Sehr schwach | 860.072 $ | +860.072 $ | 1 | |||||||||||||
| ProQR Therapeutics N.V. | PRQR | → 0 | Neutral | 801.760 $ | +801.760 $ | 1 | |||||||||||||
| SPDR SERIES TRUST | → 0 | 578.000 $ | +249.500 $ | +76,0 % | 1 | 328.500 $ | -396.852 $ | -54,7 % | 1 | 725.352 $ | +725.352 $ | 1 | |||||||
| Corvus Pharmaceuticals, Inc. | CRVS | → 0 | Neutral | 710.755 $ | +710.755 $ | 1 | |||||||||||||
| KalVista Pharmaceuticals, Inc. | KALV | → 0 | 691.459 $ | -3.681.202 $ | -84,2 % | 1 | |||||||||||||
| Arcturus Therapeutics Holdings Inc. | ARCT | → 0 | Sehr schwach | 656.219 $ | +656.219 $ | 1 | |||||||||||||
| Ventyx Biosciences, Inc. | VTYX | → 0 | 520.832 $ | +520.832 $ | 1 | ||||||||||||||
| Vanda Pharmaceuticals Inc. | VNDA | → 0 | Neutral | 520.283 $ | +520.283 $ | 1 | |||||||||||||
| Pasithea Therapeutics Corp. | KTTA | → 0 | Schwach | 458.056 $ | +458.056 $ | 1 | |||||||||||||
| AtaiBeckley Inc. | ATAI | → 0 | Schwach | 402.209 $ | +402.209 $ | 1 | |||||||||||||
| ASTRAZENECA PLC | AZN | → 0 | 180.000 $ | +180.000 $ | 1 | ||||||||||||||
| CRISPR Therapeutics AG | CRSP | → 0 | Schwach | 59.000 $ | +59.000 $ | 1 | |||||||||||||
| BOSTON SCIENTIFIC CORP | BSX | → 0 | Neutral | 25.000 $ | +25.000 $ | 1 | |||||||||||||
| AMGEN INC | AMGN | → 0 | Neutral | 15.000 $ | +15.000 $ | 1 | |||||||||||||
| Olema Pharmaceuticals, Inc. | OLMA | → 0 | Neutral | 7.500 $ | +7.500 $ | 1 | |||||||||||||
| 580.446.914 $ | -238.909.706 $ | -2,0 % | 76 | 1.036.774.422 $ | +619.223.434 $ | +297,1 % | 75 | 583.203.176 $ | +209.177.596 $ | +248,1 % | 75 | 499.059.412 $ | +252.563.146 $ | +151,0 % | 79 | ||||